Reshentha Beeby serves as Executive at Acer Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Reshentha Beeby has executed 1 insider transactions totaling $5.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 1, 2018 involved purchasing 275,000 shares valued at $5.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 1, 2018 | ACER | $5.0M | Purchase | 275,000 | $18.00 | Discretionary |
Reshentha Beeby currently holds 1,697,709 shares of Acer Therapeutics Inc. (ACER), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Reshentha Beeby has been a net buyer of ACER stock. They have purchased $5.0M and sold $0 worth of shares.
Reshentha Beeby's most recent insider trade was on Aug 1, 2018, when they purchased 275,000 shares at $18.00 per share.
Get notified when new Form 4 filings are submitted